[Homocysteine metabolism disorders as a potential predictor of preeclamsia].
Preeclampsia is one of the main causes of maternal and fetal mortality. We lack a reliable test that would identify the "at risk" group of pregnant women, thus allowing us to implement a specific prevention, management and treatment program. Recently, a number of theories regarding the pathophysiology of preeclampsia has been published. The role of vascular pathology as a result of an increase in homocysteine level is often mentioned. The aim of this paper is to review the current literature related to the pathology of preeclampsia and to evaluate the usefulness of assessment of homocysteine level and homocysteine metabolism disorders as a potential predictor of preeclamsia. Hiperhomocysteinemia is a known risk factor of cardiovascular diseases and hypertension. Different sources report a similar correlation between an increase in homocysteine level and the incidence of preeclampsia. As far as the topic of homocysteine in pregnancy is concerned, numerous questions and problems remain unanswered and unsolved. Although there exists a relationship between an increased values of homocysteine and the incidence of preeclampsia, there is not enough information about what group of patients should be included in the screening test to increase the rate of diagnosis and prevention of the most dangerous sequele.
Kajdy
Anna
A
Szpital Specjalistyczny Sw. Zofii, Warszawa.
Niemiec
Tomasz
T
D015415:Biomarkers / Q000378:metabolism; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006710:Homocysteine / Q000378:metabolism*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000378:metabolism; D008429:Maternal Welfare; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000378:metabolism*; D011247:Pregnancy; D011295:Prenatal Care / Q000458:organization & administration*; D011322:Primary Prevention / Q000458:organization & administration; D018570:Risk Assessment; D012307:Risk Factors
D015415:Biomarkers; D006710:Homocysteine